(MLCO) Melco Resorts - Overview
Stock: Casino, Resort, Gaming, Integrated, Entertainment
| Risk 5d forecast | |
|---|---|
| Volatility | 62.0% |
| Relative Tail Risk | -3.67% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.10 |
| Alpha | -14.83 |
| Character TTM | |
|---|---|
| Beta | 1.038 |
| Beta Downside | 0.951 |
| Drawdowns 3y | |
|---|---|
| Max DD | 67.96% |
| CAGR/Max DD | -0.30 |
EPS (Earnings per Share)
Revenue
Description: MLCO Melco Resorts January 11, 2026
Melco Resorts & Entertainment Ltd (NASDAQ:MLCO) develops, owns, and operates integrated casino-gaming and resort complexes across Asia and Europe, focusing on high-end hospitality, entertainment, and non-gaming amenities.
Its flagship assets include City of Dreams Macau (gaming tables, slots, luxury suites, retail, theater, and leisure facilities), Altira Macau (casino-hotel with premium dining and wellness offerings), and Studio City (cinematically themed resort with hotel, gaming, and retail components). In Europe, Melco runs the Grand Dragon casino in Taipa and a portfolio of properties in Cyprus (City of Dreams Mediterranean, plus satellite casinos in Limassol, Nicosia, Ayia Napa, and Paphos), as well as City of Dreams Manila in the Philippines.
Key recent performance indicators show FY 2023 revenue of approximately $3.0 billion, with adjusted EBITDA margin near 30% and same-store gaming revenue growth of about 10% YoY, driven by a rebound in mainland-China visitor traffic and a 5-point increase in average daily casino spend.
Primary economic drivers for Melco are Macau’s gaming tax regime, Chinese consumer confidence, and regional tourism flows; sector-wide, the shift toward integrated-resort models that blend gaming with entertainment and hospitality is expanding total addressable market size.
For a data-rich, unbiased assessment of Melco’s valuation dynamics, you may find the analyst tools on ValueRay worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 185.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.0 > 0.02 and ΔFCF/TA -4.08 > 1.0 |
| NWC/Revenue: 1.64% < 20% (prev 5.14%; Δ -3.49% < -1%) |
| CFO/TA 0.0 > 3% & CFO 0.0 > Net Income 185.0m |
| Net Debt (6.00b) to EBITDA (1.15b): 5.23 < 3 |
| Current Ratio: 1.07 > 1.5 & < 3 |
| Outstanding Shares: last quarter (131.7m) vs 12m ago -5.87% < -2% |
| Gross Margin: 36.78% > 18% (prev 0.36%; Δ 3642 % > 0.5%) |
| Asset Turnover: 66.27% > 50% (prev 58.08%; Δ 8.18% > 0%) |
| Interest Coverage Ratio: 1.30 > 6 (EBITDA TTM 1.15b / Interest Expense TTM 471.5m) |
Altman Z'' -1.52
| A: 0.01 (Total Current Assets 1.27b - Total Current Liabilities 1.18b) / Total Assets 7.60b |
| B: -0.50 (Retained Earnings -3.83b / Total Assets 7.60b) |
| C: 0.08 (EBIT TTM 612.5m / Avg Total Assets 7.79b) |
| D: -0.46 (Book Value of Equity -3.88b / Total Liabilities 8.50b) |
| Altman-Z'' Score: -1.52 = D |
Beneish M -3.15
| DSRI: 0.77 (Receivables 126.4m/146.6m, Revenue 5.16b/4.64b) |
| GMI: 0.98 (GM 36.78% / 35.90%) |
| AQI: 0.96 (AQ_t 0.14 / AQ_t-1 0.15) |
| SGI: 1.11 (Revenue 5.16b / 4.64b) |
| TATA: 0.02 (NI 185.0m - CFO 0.0) / TA 7.60b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of MLCO shares?
Over the past week, the price has changed by +9.58%, over one month by -2.73%, over three months by -30.18% and over the past year by -1.14%.
Is MLCO a buy, sell or hold?
- StrongBuy: 6
- Buy: 3
- Hold: 4
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the MLCO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.6 | 58.9% |
| Analysts Target Price | 9.6 | 58.9% |
MLCO Fundamental Data Overview February 20, 2026
P/E Forward = 8.8889
P/S = 0.426
P/B = 105.5218
P/EG = 0.0932
Revenue TTM = 5.16b USD
EBIT TTM = 612.5m USD
EBITDA TTM = 1.15b USD
Long Term Debt = 6.89b USD (from longTermDebt, two quarters ago)
Short Term Debt = 52.3m USD (from shortTermDebt, last quarter)
Debt = 7.02b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.00b USD (from netDebt column, last quarter)
Enterprise Value = 8.20b USD (2.20b + Debt 7.02b - CCE 1.02b)
Interest Coverage Ratio = 1.30 (Ebit TTM 612.5m / Interest Expense TTM 471.5m)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 8.20b)
FCF Margin = 0.0% (FCF TTM 0.0 / Revenue TTM 5.16b)
Net Margin = 3.58% (Net Income TTM 185.0m / Revenue TTM 5.16b)
Gross Margin = 36.78% ((Revenue TTM 5.16b - Cost of Revenue TTM 3.26b) / Revenue TTM)
Gross Margin QoQ = 36.68% (prev 38.83%)
Tobins Q-Ratio = 1.08 (Enterprise Value 8.20b / Total Assets 7.60b)
Interest Expense / Debt = 1.66% (Interest Expense 116.5m / Debt 7.02b)
Taxrate = 45.73% (14.5m / 31.8m)
NOPAT = 332.4m (EBIT 612.5m * (1 - 45.73%))
Current Ratio = 1.07 (Total Current Assets 1.27b / Total Current Liabilities 1.18b)
Debt / Equity = -5.64 (negative equity) (Debt 7.02b / totalStockholderEquity, last quarter -1.25b)
Debt / EBITDA = 5.23 (Net Debt 6.00b / EBITDA 1.15b)
Debt / FCF = unknown (Net Debt 6.00b / FCF TTM 0.0)
Total Stockholder Equity = -1.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.37% (Net Income 185.0m / Total Assets 7.60b)
RoE = -13.94% (negative equity) (Net Income TTM 185.0m / Total Stockholder Equity -1.33b)
RoCE = 11.02% (EBIT 612.5m / Capital Employed (Equity -1.33b + L.T.Debt 6.89b))
RoIC = 5.67% (NOPAT 332.4m / Invested Capital 5.87b)
WACC = 3.01% (E(2.20b)/V(9.22b) * Re(9.74%) + D(7.02b)/V(9.22b) * Rd(1.66%) * (1-Tc(0.46)))
Discount Rate = 9.74% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -45.11%
Fair Price DCF = unknown (Cash Flow 0.0)
EPS Correlation: 80.59 | EPS CAGR: 41.01% | SUE: 0.17 | # QB: 0
Revenue Correlation: 82.57 | Revenue CAGR: 30.62% | SUE: 0.96 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.08 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=0.56 | Chg30d=-0.119 | Revisions Net=+0 | Growth EPS=-20.0% | Growth Revenue=+3.4%
EPS next Year (2027-12-31): EPS=0.80 | Chg30d=+0.056 | Revisions Net=+0 | Growth EPS=+41.2% | Growth Revenue=+4.1%